SLC38A7

Sodium-coupled neutral amino acid transporter 7 · Q9NVC3 · SLC38A7 on Sugi Atlas →

0 patent compounds predicted against SLC38A7, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to SLC38A7 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Effect of Age on the Renal Clearance of Adefovir PHASE4WITHDRAWN
L-arginine Treatment in Mild Hypertension PHASE4UNKNOWN
Pharmacogenetic Treatment With Anti-Glutaminergic Agents for Comorbid PTSD & AUD PHASE3COMPLETED
First-in-Human Evaluation of an Astrocytic Glutamate Transporter (EAAT2) PET Tracer in Dementia PHASE1/PHASE2RECRUITING
Testing the Combination of MLN4924 (Pevonedistat), Carboplatin, and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) Who Have Previously Been Treated With Immunotherapy PHASE2ACTIVE_NOT_RECRUITING
Evaluating Safe Ketone Thresholds To Minimise Ketosis in People With Type 1 Diabetes Using Dapagliflozin PHASE2NOT_YET_RECRUITING
Influence of the OATP1B1 and OATP1B3 Genotype on the Hepatic Uptake of Primovist® PHASE1/PHASE2COMPLETED
Role of Metal Ion Transporter ZIP8 in Alcohol-Related Behaviors PHASE1RECRUITING
Identification and Validation of Biomarkers for Breast Cancer Resistance Protein (BCRP) PHASE1COMPLETED
Effect of, OAT3, on the Renal Secretion of Cefotaxime PHASE1COMPLETED
Drug-drug Interaction Study in Healthy Male Volunteers Following the Administration of Pantoprazole and Rosuvastatin PHASE1COMPLETED
Pharmacokinetic Drug-Drug Interaction Study to Identify Biomarkers of Kidney Transporters EARLY_PHASE1COMPLETED
Gadoxetate Sodium Enhanced MRI as a Biomarker for Aggressive Prostate Cancer EARLY_PHASE1UNKNOWN
Impact of Polymorphisms of OAT1, OAT3, and OCT2 on Transportation of Potential Nephrotoxic Drugs nanCOMPLETED
Brain P-gp and Inflammation in People With Epilepsy nanCOMPLETED
CRF vs WCRF or PRF-DRG in CLBP of FJ Origin and RFA Failure of MBDR: Central Sensitization and Aberrant Nerve Sprouting nanUNKNOWN
Oxalate and Citrate in Humans - Response to Citrate nanRECRUITING
Lithium Countertransport and Blood Pressure In CARDIA and TOMHS nanCOMPLETED
A Study of Cases with Abnormal Serum Ammonia in Neonate and Children Attending Assiut University Children Hospital nanNOT_YET_RECRUITING
Study of ABCB1,SLC22A16 Drug Transporter Genes and Doxorubicin and Cyclophosphamide Toxicity in Brest Cancer Patient nanUNKNOWN
Observational Study of the Impact of Genetic Testing on Healthcare Decisions and Care in Interventional Pain Management nanUNKNOWN
[18F] FDOPA PET Imaging in Glioma: Feasibility Study for PET Guided Brain Biopsy nanUNKNOWN
SLC13A5 Deficiency Natural History Study - United States Only nanENROLLING_BY_INVITATION
POTASSIUM-RICH SALT SUBSTITUTES IN KIDNEY TRANSPLANT RECIPIENTS nanNOT_YET_RECRUITING
Renal Transporters After Renal Transplantation nanUNKNOWN
Protein Digestion and Amino Acid Absorption in the Aging Gastrointestinal Tract nanCOMPLETED
Identifying Diuretic Resistance in Patients With Acute Heart Failure nanCOMPLETED
Sodium Transport: Genetics and Hypertension nanCOMPLETED
Cardiovascular Effects of Empagliflozine nanUNKNOWN
Prevalence and Risk Factors of Nephrocalcinosis in Children at Sohag University Hospital nanUNKNOWN

Related proteins — ESM-2 sequence neighbours (a SLC38A7 binder may also engage these)

ProteinNameSimilarity
A7E3U5 1.000 A7E3U5 →
Q5R9F5 1.000 Q5R9F5 →
Q8BWH0 1.000 Q8BWH0 →
Q6JWR2 1.000 Q6JWR2 →
Q8WUX1 0.994 Q8WUX1 →
Q6DEL1 0.992 Q6DEL1 →
Q6DFE7 0.991 Q6DFE7 →
Q9M8L9 0.987 Q9M8L9 →
Q3U1J0 0.985 Q3U1J0 →
A2VCW5 0.985 A2VCW5 →
Q5E9S9 0.984 Q5E9S9 →
Q28I47 0.984 Q28I47 →
Q503G8 0.984 Q503G8 →
Q99624 0.983 Q99624 →
Q9LI61 0.983 Q9LI61 →
A6NNN8 0.983 A6NNN8 →
Q5EA97 0.982 Q5EA97 →
A8KBL5 0.981 A8KBL5 →
Q9JHZ9 0.981 Q9JHZ9 →
Q8K2P7 0.981 Q8K2P7 →
Q6WWW3 0.981 Q6WWW3 →
F4KBM7 0.981 F4KBM7 →
Q28HE5 0.981 Q28HE5 →
Q9H2H9 0.980 Q9H2H9 →
G3UVW3 0.980 G3UVW3 →
D3Z813 0.979 D3Z813 →
Q8IZM9 0.979 Q8IZM9 →
Q3USY0 0.979 Q3USY0 →
A2VE31 0.978 A2VE31 →
Q9JM15 0.978 Q9JM15 →